Regulatory effect of vitamin D3 on proinflammatory processes in liver of diabetic mice

Authors

  • D. O. Labudzynskyi Palladin Institute of Biochemistry of the NAS of Ukraine, Kiev
  • K. I. Kubaichuk Palladin Institute of Biochemistry of the NAS of Ukraine, Kiev
  • I. O. Shymanskyi Palladin Institute of Biochemistry of the NAS of Ukraine, Kiev
  • M. M. Veliky Palladin Institute of Biochemistry of the NAS of Ukraine, Kiev

DOI:

https://doi.org/10.15407/dopovidi2016.06.127

Keywords:

cytokines, diabetes mellitus, vitamin D3

Abstract

It is shown that the induction of pluripotent proinflammatory interleukin 6 (IL-6) in liver in diabetes is accompanied by increased expression of osteopontin (OPN) — molecular regulator of the synthesis of proinflammatory cytokines. Changes in the OPN and IL-6 expression correlate with a significant deficiency of vitamin D3 in organism. Normalization of the vitamin D3 level leads to a substantial reduction of the expression level of both OPN and IL-6 mRNA, showing the cytoprotective effect of cholecalciferol in diabetes-induced liver disorders.

Downloads

References

Todd J. A. Immunity, 2010, 32, No 4: 457–467. https://doi.org/10.1016/j.immuni.2010.04.001

Diaz-Valencia P. A., Bougn`eres P., Valleron A. J. BMC Public Health, 2015, 15, No 255: 1–15.

Giacco F., Brownlee M. Circ. Res., 2010, 107, No 9: 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545

Ban C. R., Twigg S. M. Vasc. Health Risk Manag., 2008, 4, No 3: 575–596.

Bastard J. P., Maachi M., Lagathu C., Kim M. J., Caron M., Vidal H., Capeau J., Feve B. Eur. Cytokine Netw., 2006, 17, No 1: 4–12.

Kristiansen O. P., Mandrup-Poulsen T. Diabetes, 2005, 54, No 2: 114–124. https://doi.org/10.2337/diabetes.54.suppl_2.S114

Kahles F., Findeisen H. M., Bruemmer D. Mol. Metab., 2014, 3, No 4: 384–393. https://doi.org/10.1016/j.molmet.2014.03.004

Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Curr. Opin. Pharmacol., 2010, 10, No 4: 482–496. https://doi.org/10.1016/j.coph.2010.04.001

Labudzynskyi D. O., Shymansky I. O., Riasniy V. M., Veliky M. M. Ukr. Biochem. J., 2014, 86, No 2: 107–118. https://doi.org/10.15407/ubj86.02.107

Marcotorchino J., Romier B., Gouranton E., Riollet C., Gleize B., Malezet-Desmoulins C., Landrier J. F. Mol. Nutr. Food Res., 2012, 56, No 5: 725–732. https://doi.org/10.1002/mnfr.201100623

Yang Y., Gao S. G., Zhang F. J., Luo W., Xue J. X., Lei G. H. Eur. Rev. Med. Pharmacol. Sci., 2014, 18, No 23: 3580–3586.

Staal A., Van Wijnen A. J., Desai R. K., Pols H. A., Birkenhäger J. C., Deluca H. F., Denhardt D. T., Stein J. L., Van Leeuwen J. P., Stein G. S., Lian J. B. Endocrinology, 1996, 137, No 5: 2001–2011.

Lau W. L., Leaf E. M., Hu M. C., Takeno M. M., Kuro-o M., Moe O. W., Giachelli C. M. Kidney Int., 2012, 82, No 12: 1261–1270. https://doi.org/10.1038/ki.2012.322

Haussler M. R., Jurutka P. W., Mizwicki M., Norman A. W. Best. Pract. Res. Clin. Endocrinol. Metab., 2011, 25, No 4: 543–559. https://doi.org/10.1016/j.beem.2011.05.010

Published

03.11.2024

How to Cite

Labudzynskyi, D. O., Kubaichuk, K. I., Shymanskyi, I. O., & Veliky, M. M. (2024). Regulatory effect of vitamin D3 on proinflammatory processes in liver of diabetic mice . Reports of the National Academy of Sciences of Ukraine, (6), 127–132. https://doi.org/10.15407/dopovidi2016.06.127